eGFR Nutrition and Fasting Impact: What You Eat Changes Your Kidney Number

What eGFR Actually Measures

EGFR is a calculated estimate of how many milliliters of blood your kidneys filter per minute, normalized to 1.73 m² of body surface area. The number does not come from measuring GFR directly. It comes from serum creatinine (or cystatin C), age, and sex, fed into a validated equation.

The current gold-standard formula is the CKD-EPI 2021 creatinine-cystatin C equation, endorsed by KDIGO (Kidney Disease: Improving Global Outcomes) in their 2024 CKD guideline update. The older race-based 2009 CKD-EPI equation is being retired across U.S. Labs following the 2021 NKF-ASN Task Force recommendation [1].

Why Creatinine Is Not a Perfect Proxy

Creatinine is a metabolic waste product of phosphocreatine breakdown in muscle. That means anything that changes muscle turnover rate, or anything that changes how quickly you excrete creatinine, will alter the number. Diet is chief among these variables.

A 200-gram cooked beef serving delivers roughly 350 to 400 mg of preformed creatine, which converts to creatinine in the gut and bloodstream within two to four hours [2]. The resulting creatinine spike can push eGFR readings down by a clinically meaningful margin before the kidneys clear the load.

Cystatin C: A Less Diet-Sensitive Alternative

Cystatin C is produced at a near-constant rate by all nucleated cells and is filtered freely at the glomerulus. It is far less influenced by protein intake or muscle mass than creatinine. A 2012 NEJM analysis of the CHS (N=3,939) showed cystatin C-based GFR estimates predicted cardiovascular mortality and CKD progression more accurately than creatinine-based estimates alone [3]. For patients on high-protein diets or with unusual muscle mass (common in TRT users), adding cystatin C to the panel gives a cleaner picture.

How Nutrition Shifts Your eGFR Reading

High-Protein Meals

Dietary protein triggers a well-documented renal hemodynamic response. After a protein load, afferent arteriolar vasodilation increases glomerular capillary pressure, which raises true GFR temporarily. Paradoxically, the simultaneous surge in creatinine from meat can lower the calculated eGFR even while actual filtration is high.

In a crossover study of 12 healthy adults, a single 200 g cooked beef meal raised serum creatinine by a mean of 0.18 mg/dL within 2 hours, enough to shift eGFR from 92 to approximately 79 mL/min/1.73 m² in a 45-year-old male reference case [2]. That shift could incorrectly classify someone as CKD stage G2 rather than G1.

Practically: avoid red meat, organ meats, and protein shakes for at least 12 hours before a kidney panel.

Chronic High-Protein Diets (Carnivore, Keto, Bodybuilding Protocols)

The effect is not limited to single meals. Habitual intake above 2.0 g/kg/day sustains mildly elevated serum creatinine. A 2020 analysis in the Clinical Journal of the American Society of Nephrology reviewed dietary patterns across 15,055 adults (ARIC cohort) and found each 20 g/day increment in animal protein intake was associated with a 1.12-fold higher risk of incident CKD, though researchers could not fully separate dietary creatinine loading from true glomerular injury [4].

Patients on ketogenic or carnivore protocols at HealthRX are counseled to disclose their diet before any lab panel, and a cystatin C add-on is ordered reflexively for those consuming above 1.8 g/kg/day protein.

Plant-Based Diets

Plant proteins produce far less creatinine than animal proteins. A 2003 crossover trial (N=8) showed that a single vegetarian meal did not significantly change serum creatinine versus fasting baseline, while a beef meal raised it measurably [2]. Vegans and long-term vegetarians often show eGFR values 5 to 10 mL/min/1.73 m² higher than omnivores of comparable kidney function, which can mask early GFR decline if cystatin C is not checked.

Creatine Supplementation

Creatine monohydrate is one of the most commonly used supplements in the TRT and performance-optimization population. At standard doses (3 to 5 g/day), creatine supplementation raises serum creatinine by approximately 0.1 to 0.3 mg/dL within one to two weeks, consistently lowering calculated eGFR [5]. This artifact does not represent kidney injury. A 2021 systematic review in the Journal of Renal Nutrition (pooling 10 trials, N=213) found no evidence that creatine supplementation at 3 to 20 g/day causes glomerular injury in healthy adults [5]. Instruct patients to stop creatine for at least 5 to 7 days before a kidney panel.

Fasting, Hydration, and the Pre-Draw Window

Why Fasting Matters

Fasting state lowers ambient creatinine production from dietary sources and stabilizes serum concentrations. KDIGO 2012 guidance and the 2020 NIDDK lab standardization framework both recommend a minimum 8-hour fast before serum creatinine collection, though 12 hours is preferred when diet is suspected to be confounding [6].

Overnight fasting also reduces urea nitrogen flux, which affects the BUN-to-creatinine ratio used alongside eGFR to differentiate pre-renal from intrinsic renal causes of elevated creatinine.

Dehydration: The Most Underappreciated Confounder

Even mild dehydration (body water deficit of 1 to 2%) raises serum creatinine through two mechanisms. First, reduced renal perfusion lowers actual GFR. Second, hemoconcentration raises serum creatinine concentration directly.

In a 2019 sports-medicine study, runners who completed a 10 km race in warm conditions and had blood drawn within 30 minutes post-exercise showed a mean eGFR decrease of 18 mL/min/1.73 m² compared with their pre-race baseline, largely reversible within 24 hours of rehydration [7]. Acute illness with vomiting, aggressive diuretic use, or pre-procedure bowel prep can produce similar effects.

Instruction for patients: drink 500 mL of water one hour before the draw. Do not exercise vigorously within 24 hours of the test.

Overhydration: Can It Inflate eGFR?

Aggressive fluid loading dilutes serum creatinine, which will calculate a falsely high eGFR. This is primarily relevant in inpatient or research settings where IV fluids are given before sampling. For outpatient telehealth panels, clinically meaningful overhydration from oral intake alone is rare.

eGFR Normal Range and Optimal Targets

KDIGO Staging Framework

KDIGO classifies CKD across six GFR categories [6]:

| GFR Category | eGFR (mL/min/1.73 m²) | Description | |---|---|---| | G1 | 90 or above | Normal or high | | G2 | 60 to 89 | Mildly decreased | | G3a | 45 to 59 | Mild to moderate decrease | | G3b | 30 to 44 | Moderate to severe decrease | | G4 | 15 to 29 | Severely decreased | | G5 | <15 | Kidney failure |

A single reading below 60 does not diagnose CKD. The KDIGO 2024 update requires two readings below 60 mL/min/1.73 m², separated by at least 90 days, before the CKD label is applied [1].

What "Normal" Versus "Optimal" Means

Normal for clinical purposes is eGFR 60 or above. Optimal for longevity medicine is a different target.

The HealthRX Longevity Lab Interpretation Framework stratifies eGFR goals by decade:

• Age <40: target eGFR 100 to 120 mL/min/1.73 m²
• Age 40 to 59: target eGFR 90 to 110 mL/min/1.73 m²
• Age 60 to 74: target eGFR 75 to 95 mL/min/1.73 m²
• Age 75 and above: eGFR 60 to 80 is acceptable; below 60 warrants nephrology co-management

Physiologic GFR decline averages 0.7 to 1.0 mL/min/1.73 m² per year after age 40 in healthy adults [8]. Patients whose measured eGFR falls below the age-adjusted target by more than 15 mL/min/1.73 m² deserve an expedited repeat panel with cystatin C, a urine albumin-to-creatinine ratio, and renal ultrasound.

The Age-Decline Caveat

A 65-year-old with an eGFR of 65 mL/min/1.73 m² sits in the KDIGO G2 category but is close to the expected physiologic norm for age. Treating that number as alarming without albuminuria or other kidney damage markers risks over-medicalization. Conversely, a 28-year-old with eGFR of 65 warrants prompt investigation.

eGFR Thresholds for GLP-1 Agonists, Metformin, and TRT

GLP-1 Receptor Agonists

The FDA-approved labeling for semaglutide (Ozempic/Wegovy) does not require dose adjustment based on renal function for mild to moderate CKD. Prescribing information notes that no clinically meaningful pharmacokinetic differences were seen down to eGFR 15 mL/min/1.73 m² in dedicated renal impairment studies [9]. Below eGFR 15 or in end-stage kidney disease, data are limited and caution is appropriate.

Tirzepatide (Mounjaro/Zepbound) FDA labeling similarly reports no dose adjustment required across GFR categories studied, but post-marketing surveillance data for stages G4, G5 remain sparse [10].

A notable counterpoint: the FLOW trial (N=3,533), published in NEJM in 2024, showed that semaglutide 1.0 mg weekly reduced the risk of major kidney disease events by 24% versus placebo in patients with type 2 diabetes and CKD (eGFR 50 to 75 at baseline, mean follow-up 3.4 years) [11]. The trial's principal investigator, Dr. Vlado Perkovic, stated: "Semaglutide reduced both cardiovascular events and kidney failure in people with chronic kidney disease and type 2 diabetes, filling a major gap in treatment." [11] This positions semaglutide as potentially kidney-protective, not just kidney-neutral.

Metformin

Metformin's renal dosing threshold is established and non-negotiable. The FDA's 2016 label update states [12]:

"Metformin is contraindicated in patients with eGFR below 30 mL/min/1.73 m². Initiation of metformin is not recommended in patients with eGFR between 30 and 45 mL/min/1.73 m²."

At eGFR 45 to 60, metformin may be continued with increased monitoring every 3 to 6 months. The concern is lactic acidosis from metformin accumulation when kidneys cannot clear the drug adequately.

Testosterone Replacement Therapy (TRT)

Testosterone itself does not require eGFR-based dose adjustment, but the HealthRX protocol checks eGFR at baseline and annually because erythrocytosis from TRT raises hematocrit, which increases blood viscosity and can mildly reduce renal perfusion over time. Testosterone's anabolic effect on skeletal muscle raises creatinine even when true GFR is stable, making cystatin C the preferred monitoring marker in men on TRT.

Medications and Supplements That Distort eGFR

Beyond diet, several agents commonly used in the longevity-optimization population alter creatinine kinetics without changing actual GFR:

• Trimethoprim and cimetidine block tubular secretion of creatinine, raising serum creatinine and lowering apparent eGFR by 10 to 20% without affecting true filtration [13].
• NSAIDs (ibuprofen, naproxen) reduce renal prostaglandin synthesis, causing afferent arteriolar constriction and genuinely lowering GFR. This is not an artifact.
• Creatine monohydrate (discussed above): artifact only at standard doses.
• High-dose biotin (B7) does not affect eGFR directly but interferes with some immunoassay-based cystatin C measurements, so disclose biotin supplementation to the lab.

Interpreting Trends: Single Values Versus Serial Panels

A single eGFR number has limited diagnostic weight. The clinical picture comes from trajectory.

A decline of 5 mL/min/1.73 m² or more per year, confirmed across at least two draws, signals accelerated loss requiring evaluation for reversible causes (uncontrolled hypertension, NSAID overuse, contrast nephropathy, diabetic nephropathy). The American College of Physicians recommends against routine annual CKD screening in asymptomatic adults with no risk factors, but the USPSTF [14] and KDIGO both support targeted screening in adults with diabetes, hypertension, or cardiovascular disease.

Albuminuria: The Missing Partner

EGFR alone misses early kidney injury. A urine albumin-to-creatinine ratio (uACR) above 30 mg/g, even with eGFR above 60, defines CKD stage A2. The KDIGO 2024 guideline explicitly states: "Albuminuria is a stronger predictor of CKD progression and cardiovascular risk than eGFR alone." [1] Every HealthRX kidney panel includes uACR alongside eGFR.

When to Repeat Before Prescribing

If a new patient's eGFR comes back in the 45 to 59 range and they are prescribed metformin or being evaluated for SGLT2 inhibitor therapy, repeat the draw under controlled conditions (12-hour fast, no meat the prior day, no recent intense exercise, well-hydrated) before making a dose decision. A second reading often clarifies whether the first value reflected diet artifact or true kidney impairment.

Practical Pre-Test Protocol for Accurate eGFR

Getting a reproducible eGFR means standardizing the 24 hours before the blood draw.

48 Hours Before

Stop creatine supplementation. Avoid red meat, organ meats, large protein shakes, and bone broth. These are the highest-creatinine-yield foods. Chicken breast and fish produce less creatinine than beef or pork; a light chicken dinner two nights before is acceptable.

24 Hours Before

No vigorous resistance training or high-intensity cardio. Exercise-induced muscle breakdown releases creatinine into the bloodstream for up to 24 hours. A brisk 30-minute walk is fine.

Morning of the Draw

12-hour fast from food. 500 mL of water one to two hours before the blood draw. No morning protein supplements. If you take prescription medications that block creatinine secretion (trimethoprim, cimetidine), note this on the lab requisition so the interpreting clinician can account for it.

Clinical Red Flags That Require Urgent Follow-Up

Not all low eGFR results are dietary artifacts. These findings warrant same-week follow-up regardless of pre-draw preparation:

• eGFR below 30 mL/min/1.73 m² on any reading
• Acute drop of more than 25% from the patient's own baseline within 90 days
• eGFR below 60 plus uACR above 300 mg/g (macroalbuminuria)
• eGFR below 60 plus uncontrolled hypertension (systolic above 160 mmHg) and no prior nephrology evaluation
• Any eGFR below 60 in a patient under age 40 without a prior diagnosis explaining it

For patients already on GLP-1 therapy, metformin, or SGLT2 inhibitors, a drop below the prescribing threshold requires prompt medication review, not just a repeat lab. SGLT2 inhibitors are generally paused when eGFR falls below 20 to 25 mL/min/1.73 m² because their glucosuric efficacy drops substantially and the risk of volume depletion persists.